Rimonabant drug molecule

Rimonabant drug molecule

A624/0357 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 46.6MB

Downloadable file size: 750.7KB

Price image Pricing

Please login to use the price calculator


Credit: DR TIM EVANS/SCIENCE PHOTO LIBRARY

Caption: Rimonabant. Computer model of a molecule of the anti-obesity drug rimonabant. This drug works by suppressing the patient's appetite. It has been developed by Sanofi-Aventis, and will be sold under the brand names Acomplia and Zimulti. On 21 June 2006, it was approved for use in the European Union. Approval has not yet been granted by the licensing authorities in the USA. The molecule's chemical formula is C22.H21.Cl3.N4.O. Atoms (tubes) are colour-coded: carbon (yellow), hydrogen (white), chlorine (green), nitrogen (dark blue), oxygen (red).

Release details: Model release not required. Property release not required.

Keywords: acomplia, anorectic, appetite suppressant, artwork, biochemical, biochemistry, chemical, chemicals, chemistry, compound, compounds, computer artwork, drug, drugs, fat, illustration, medical, medicine, molecular, molecular model, molecule, molecules, obese, obesity, organic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, rimonabant, rods, sanofi-aventis, stick, structural, structure, treatment, tubes, tubular, zimulti

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.